Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bacci

Showing results (191-200 of 217) with videos related to

Pageof 22
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 30, 2000
Granisetron, tropisetron, and ondansetron in the prevention of acute emesis induced by a combination of cisplatin-Adriamycin and by high-dose ifosfamide delivered in multiple-day continuous infusionsC Forni, S Ferrari, L Loro, et al.
Bone Marrow Transplantation|February 16, 1999
Feasibility of high-dose chemotherapy and autologous peripheral blood stem cell transplantation in children with high grade osteosarcomaR Miniero, A Brach del Prever, E Vassallo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated reportG Bacci, S Ferrari, F Bertoni, et al.
La Chirurgia Degli Organi Di Movimento|January 1, 1995
Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: excellent response of the primary tumor to preoperative treatment with methotrexate, cisplatin, adriamycin, and ifosfamide. Preliminary resultsG Bacci, P Picci, S Ferrari, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 19, 2004
Osteosarcoma of the pelvisD Donati, S Giacomini, E Gozzi, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1992
Effect of intra-arterial versus intravenous cisplatin in addition to systemic adriamycin and high-dose methotrexate on histologic tumor response of osteosarcoma of the extremitiesG Bacci, P Picci, M Avella, et al.
Cancer|December 1, 1993
Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicinG Bacci, P Picci, S Ferrari, et al.
Cancer|June 1, 1990
Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatinG Bacci, P Picci, P Ruggieri, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2002
Neoadjuvant chemotherapy for Ewing's tumour of bone: recent experience at the Rizzoli Orthopaedic InstituteG Bacci, M Mercuri, A Longhi, et al.
Journal of Chemotherapy (Florence, Italy)|January 6, 1999
Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremityS Ferrari, M Mercuri, P Rosito, et al.
Pageof 22

Showing results (191-200 of 217) with videos related to

Sort By:
Pageof 22
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 30, 2000
Granisetron, tropisetron, and ondansetron in the prevention of acute emesis induced by a combination of cisplatin-Adriamycin and by high-dose ifosfamide delivered in multiple-day continuous infusionsC Forni, S Ferrari, L Loro, et al.
Bone Marrow Transplantation|February 16, 1999
Feasibility of high-dose chemotherapy and autologous peripheral blood stem cell transplantation in children with high grade osteosarcomaR Miniero, A Brach del Prever, E Vassallo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated reportG Bacci, S Ferrari, F Bertoni, et al.
La Chirurgia Degli Organi Di Movimento|January 1, 1995
Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: excellent response of the primary tumor to preoperative treatment with methotrexate, cisplatin, adriamycin, and ifosfamide. Preliminary resultsG Bacci, P Picci, S Ferrari, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 19, 2004
Osteosarcoma of the pelvisD Donati, S Giacomini, E Gozzi, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1992
Effect of intra-arterial versus intravenous cisplatin in addition to systemic adriamycin and high-dose methotrexate on histologic tumor response of osteosarcoma of the extremitiesG Bacci, P Picci, M Avella, et al.
Cancer|December 1, 1993
Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicinG Bacci, P Picci, S Ferrari, et al.
Cancer|June 1, 1990
Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatinG Bacci, P Picci, P Ruggieri, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2002
Neoadjuvant chemotherapy for Ewing's tumour of bone: recent experience at the Rizzoli Orthopaedic InstituteG Bacci, M Mercuri, A Longhi, et al.
Journal of Chemotherapy (Florence, Italy)|January 6, 1999
Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremityS Ferrari, M Mercuri, P Rosito, et al.
Pageof 22